NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!

Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.

Start Free »

CRVL | NASDAQ

$75.34 $0.79 | 1.06%

SIGNAL:

|2026-09-25 |F&G 74 |RSI 70.1

Add to favoritesFavorite

Company Overview:

Market Cap: $3.83B

Trailing PE: 33.5x

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $44.83 - $79.43

10 Year CRVL Performance Metrics:

Total Return (with DRIP): 491.4% (19.45% CAGR)

Total Return (no DRIP): 491.4% (19.45% CAGR)

Share Price: 488.6% (19.39% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $59,137

Total Return $ (with DRIP): $49,137

CRVL Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

CRVL Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

CRVL Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

CRVL - Revenue

CRVL Revenue CAGR:1Y: 10.74%2Y: 10.80%5Y: 11.24%10Y: 7.30%

CRVL - Earnings Per Share (EPS)

CRVL EPS CAGR:1Y: 21.15%2Y: 22.47%5Y: -7.29%10Y: 5.19%

CRVL - Net Income

🔓 See the full chart40% off right now · 7-day free trial

CRVL Net Income CAGR:1Y: 18.32%2Y: 22.21%5Y: 13.86%10Y: 15.71%

CRVL - EBITDA

🔓 See the full chart40% off right now · 7-day free trial

CRVL EBITDA CAGR:1Y: 21.54%2Y: 22.43%5Y: 14.51%10Y: 11.74%

CRVL - Free Cash Flow

🔓 See the full chart40% off right now · 7-day free trial

CRVL Free Cash Flow CAGR:1Y: 8.94%2Y: 14.67%5Y: 40.05%10Y: 31.17%

CRVL - Free Cash Flow / Share

🔓 See the full chart40% off right now · 7-day free trial

CRVL Free Cash Flow / Share CAGR:1Y: 10.12%2Y: 15.30%5Y: 41.61%10Y: 33.43%

CRVL - Operating Income

🔓 See the full chart40% off right now · 7-day free trial

CRVL Operating Income CAGR:1Y: 22.84%2Y: 24.34%5Y: 16.08%10Y: 13.59%

CRVL - Gross Profit

🔓 See the full chart40% off right now · 7-day free trial

CRVL Gross Profit CAGR:1Y: 4.00%2Y: 10.72%5Y: 9.67%10Y: 8.72%

CRVL - Shares Outstanding

🔓 See the full chart40% off right now · 7-day free trial

CRVL Shares Outstanding CAGR:1Y: -1.90%2Y: -0.98%5Y: 22.82%10Y: 9.93%

CRVL - Share Buybacks

🔓 See the full chart40% off right now · 7-day free trial

CRVL Share Buybacks CAGR:1Y: 128.43%2Y: 51.86%5Y: 9.13%10Y: 29.56%

CRVL - Stock-Based Comp

🔓 See the full chart40% off right now · 7-day free trial

CRVL Stock-Based Comp CAGR:1Y: -4.02%2Y: 12.74%5Y: 0.22%10Y: 10.18%

CRVL - Expenses

🔓 See the full chart40% off right now · 7-day free trial

CRVL Expenses CAGR:1Y: -55.79%2Y: -5.61%5Y: 1.13%10Y: 2.61%

CRVL - Revenue vs Net Income

🔓 See the full chart40% off right now · 7-day free trial

CRVL - EPS vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

CRVL - EPS vs PE Ratio

🔓 See the full chart40% off right now · 7-day free trial

CRVL - FCF vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

CRVL - FCF vs Stock Based Comp

🔓 See the full chart40% off right now · 7-day free trial

CRVL - Cash & Debt

🔓 See the full chart40% off right now · 7-day free trial

CRVL - Revenue by Segment

🔓 See the full chart40% off right now · 7-day free trial

CRVL Revenue CAGR:1Y: 10.74%2Y: 10.80%5Y: 11.24%10Y: 7.30%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

CRVL - REVENUE: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

CRVL Actual Revenue CAGR:1Y: 10.74%2Y: 10.80%5Y: 11.24%10Y: 7.30%

CRVL - EPS: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

CRVL Actual EPS CAGR:1Y: 21.15%2Y: 22.47%5Y: -7.29%10Y: 5.19%

CRVL - NET INCOME: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

CRVL Actual Net Income CAGR:1Y: 18.32%2Y: 22.21%5Y: 13.86%10Y: 15.71%

CRVL - EBITDA: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

CRVL Actual EBITDA CAGR:1Y: 21.54%2Y: 22.43%5Y: 14.51%10Y: 11.74%

Ratios, Profit Margins & Return on Capital:

CRVL - Net Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

CRVL Net Profit Margin CAGR:1Y: 6.90%2Y: 10.31%5Y: 2.35%10Y: 7.84%

CRVL - Gross Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

CRVL Gross Profit Margin CAGR:1Y: -6.08%2Y: -0.07%5Y: -1.41%10Y: 1.32%

CRVL - Price to Earnings

🔓 See the full chart40% off right now · 7-day free trial

CRVL Price to Earnings CAGR:1Y: -48.83%2Y: -29.57%5Y: -7.23%10Y: -1.87%

CRVL - Price To Sales Ratio

🔓 See the full chart40% off right now · 7-day free trial

CRVL Price To Sales Ratio CAGR:1Y: -45.66%2Y: -22.58%5Y: -4.95%10Y: 6.11%

CRVL - Return on Capital Employed

🔓 See the full chart40% off right now · 7-day free trial

CRVL Return on Capital Employed CAGR:1Y: 3.55%2Y: 1.37%5Y: 5.79%10Y: 2.12%

CRVL - Return on Invested Capital

🔓 See the full chart40% off right now · 7-day free trial

CRVL Return on Invested Capital CAGR:1Y: 0.10%2Y: 0.26%5Y: 4.37%10Y: 3.85%

Projected Future Returns & Dividends for CRVL

Based on past 10-year performance, here are CRVL growth metrics:

Share price CAGR of +19.39%
Dividend CAGR of +0%

Using CRVL CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	CRVL (DRIP)	CRVL - No DRIP
Current Price	$75.34	$75.34
Start Shares	132.73	132.73
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	132.73	132.73
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$75.34	$75.34
Total Dividends	$0	$0
Final Value	$10,000	$10,000

Estimated Future Value + Dividends - CRVL

NOTE: Above numbers are our estimate based on CRVL's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

CorVel Corporation (CRVL) had its IPO on 1991-06-28, and is traded on NASDAQ stock exchange.

CorVel Corporation delivers comprehensive solutions designed to assist employers, third-party administrators, insurance providers, and government entities in effectively managing healthcare claims. The company focuses on controlling medical expenditures and ensuring high-quality care across various sectors, including workers' compensation, auto liability, and general health. Leveraging advanced technologies such as artificial intelligence, machine learning, and natural language processing, CorVel enhances the oversight of entire healthcare episodes and their associated costs. Their service portfolio includes a wide array of network solutions, featuring automated medical fee auditing, management and reimbursement for preferred providers, retrospective utilization reviews, and detailed scrutiny of both facility and professional claims. Additionally, they offer pharmacy services, directed care programs, Medicare solutions, clearinghouse functionalities, independent medical examinations, and inpatient medical bill reviews. Beyond network services, CorVel provides a suite of patient management offerings, encompassing claims and case management, round-the-clock nurse triage, utilization management, vocational rehabilitation, and life care planning. The company also processes property and casualty claims specifically for self-insured clients. Established in 1987, CorVel maintains its corporate headquarters in Fort Worth, Texas.

CRVL website: https://www.corvel.com

Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

DCF Model — CRVL

Value from:

EPS (TTM)icompany profit per share over the last 12 months

EPS Growth %ihow fast profit per share grows each of the next 5 years — prefilled with what analysts expect

EPS growth after year 5 (forever)ithe slower pace once the fast 5 years are over — only drives years 6-10 of the price path below

Exit multiple (PE in 5 yrs)iwhat buyers pay per $1 of profit in 2031 — prefilled with today’s forward PE

Desired return %/yrithe yearly return you want from buying today — the S&P has done ~14%/yr, ask for more from a single stock

FCF growth %/yr (next 5 yrs)ihow fast free cash flow grows while the company is still expanding fast

Years of fast FCF growthihow many years the fast growth lasts before the business settles down

FCF growth after year 5 (forever)ithe slow, steady pace once the company is mature — usually 2-3%, near inflation. Must stay below your target return

Risk-free rate %iwhat a 10-yr US treasury pays with zero risk — the floor any risky stock must beat

Your target return %/yrithe yearly return you want for taking this risk — rule of thumb: risk-free rate + extra for risk

FCF base ($M, TTM)ilast 12 months of free cash flow, added up from reported quarters

Include dividends in returnidividends hand you part of the return in cash, so the share price needs to climb less

Pay up to today

—

vs current price $75.34

—

Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today

—

grows for the next years

Then mature

—

every future dollar counted back to today

Pile of today-dollars

—

÷ shares

Implied price path

Year	FCF	Implied price

Sensitivity — fair value: growth ↓ × target return →